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Background: Nursing home patients with dementia use psychotropic drugs longer and more frequently than
recommended by guidelines implying psychotropic drugs are not always prescribed appropriately. These drugs
can have many side effects and effectiveness is limited. Psychotropic drug use between nursing home units varies
and is not solely related to the severity of neuropsychiatric symptoms. There is growing evidence indicating that
psychotropic drug use is associated with environmental factors, suggesting that the prescription of psychotropic
drugs is not only related to (objective) patient factors. However, other factors related to the patient, elderly care
physician, nurse and the physical environment are only partially identified. Using a mixed method of qualitative
and quantitative research, this study aims to understand the nature of psychotropic drug use and its underlying
factors by identifying: 1) frequency and appropriateness of psychotropic drug use for neuropsychiatric symptoms
in nursing home patients with dementia, 2) factors associated with (appropriateness of) psychotropic drug use.
Methods: A cross-sectional mixed methods study. For the quantitative study, patients with dementia (n = 540), nursing
staff and elderly care physicians of 36 Dementia Special Care Units of 12 nursing homes throughout the Netherlands will
be recruited. Six nursing homes with high average rates and six with low average rates of psychotropic drug use, based
on a national survey about frequency of psychotropic drug use on units, will be included. Psychotropic drugs include
antipsychotics, anxiolytics, hypnotics, antidepressants, anticonvulsants and anti-dementia drugs. Appropriateness will be
measured by an instrument based on the Medication Appropriateness Index and current guidelines for treatment of
neuropsychiatric symptoms. Factors associated to psychotropic drug use, related to the patient, elderly care physician,
nurse and physical environment, will be explored using multilevel regression analyses. For the qualitative study, in depth
interviews with staff will be held and analyzed to identify and explore other unknown factors.
Discussion: This study will provide insight into factors that are associated with the frequency and appropriateness of
psychotropic drug use for neuropsychiatric symptoms. Understanding psychotropic drug use and its associations may
contribute to better dementia care.
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In the Netherlands approximately 37.000 patients with de-
mentia reside in Dementia Special Care Units (DSCUs) of
nursing homes [1,2]. The prevalence of neuropsychiatric
symptoms (NPS) associated with dementia is high, more
than 80% [3], and frequently a reason for prescription of
psychotropic drugs (PDs) [4-6]. However, psychosocial in-
terventions and restraints are also commonly used in the
management of NPS [7]. Psychotropic drug use (PDU)
rates in institutionalized patients with dementia vary from
63%-75% [6,8,9]. It is also known that antipsychotic use
varies among countries between 11% and 52% [6,10-12].
PDs have considerable side effects. Antipsychotics are
associated with increased occurrence of extrapyramidal
symptoms, somnolence, increased risk for stroke and
pneumonia and higher mortality rates [13-15]. Anxio-
lytic and hypnotic drugs are associated with falls [16].
PDs in general [17] and antipsychotics in particular also
have negative effects on quality of life [18].
Long-term or inappropriate use of antipsychotics is
common [19], a recent study found that 31% of the nur-
sing home patients used PDs for a sustained period of at
least 2 years [9] and in another study 74% of dementia pa-
tients in nursing homes used PDs for 83% of their nursing
home stay [20]. This does not comply with available evi-
dence on risks, side effects, limited evidence for efficacy of
these drugs and long-term inefficacy [15,21,22]. That is
why guidelines emphasize the restricted, short-term use
and thus the appropriateness of PDU [23].
PDU varies considerably among nursing homes and
DSCUs [24,25]. This could partly be explained by different
prevalence rates of NPS among patients on DSCUs [3].
However there is growing evidence that this inter-DSCU
variation in PDU is not only related to the severity of pa-
tients’ NPS [6,26]. The PDU variation is also related to
drug prescription policies of the Elderly Care Physician
(ECP) [5], staff distress/workload [26], physical environ-
mental factors [25], and the bed capacity of the nursing
home [27] (see Figure 1).
Although studies [26,27] investigated frequency of PDU
and its associated environmental factors a large propor-
tion, 80%, of the variation in PDU between DSCUs is un-
explained [25]. The unexplained variation of PDU, the
long-term use and the inter-DSCU variation raise ques-
tions not only about appropriateness of prescription, but
also about factors associated with the variation in fre-
quency and appropriateness of PDU. That is why we
propose a conceptual framework of PDU and four cat-
egories of factors with which PDU is hypothesized to be
associated: patient, ECP, nurse and physical environment.
More specifically, possible other associations related to
PDU are: 1. patients’ demographic characteristics and in-
fluence of psychosocial environment (relatives and other
patients) 2. physicians’ demographic characteristics andattitude to dementia care 3. nurses’ job satisfaction, experi-
enced organizational culture, demographic characteristics
and attitude to dementia care 4. the physical environment,
e.g. nursing home characteristics and DSCU characteristics.
Depicted in the conceptual framework we hypothesize
that PDU frequency and appropriateness are associated
with these four categories of factors, the use of psycho-
social interventions and restraints are seen as alternatives
to PDU in the framework (see Figure 1). To obtain full
insight in (possible) associations mixed methods of quan-
titative and qualitative research will be used.
We aim to study: 1. the frequency and appropriateness
of PDU for NPS in nursing home patients with dementia
2. factors associated with frequency and appropriateness




This study, the PROPER I study (PRescription Opti-
mization of Psychotropic drugs in Elderly nuRsing home
patients with dementia) is a cross-sectional mixed methods
study and will be followed by the PROPER II study [28], a
multi-center cluster randomized controlled, pragmatic trial
on the efficacy of structured repeated multidisciplinary re-
view on psychotropic drugs. The eligibility of nursing
homes is based on a survey among ECPs working in nurs-
ing homes that we will carry out among all members of
Verenso, the Dutch association of ECPs and community
geriatricians. ECPs will be asked to count the number of
patients, living on the DSCU they are responsible for, that
receive one or more PDs. Nursing homes will be eligible if
their ECPs fill in the survey about PDU for at least 3
DSCUs.
Study population and recruitment
According to our calculations (see section on Sample size),
36 DSCUs need to be recruited. Based on the results of the
survey, 36 DSCUs will be divided over six nursing homes
with high and six with low DSCU overall PDU rates.
DSCUs with medium rates will be accepted if the nursing
home’s overall rate is high or low on average; at least two
out of three DSCUs need to score high or low within a
nursing home. With this selection method the contrast in
PDU among nursing homes is increased, which could fa-
cilitate finding relevant parameters of PDU, without loss of
statistical dispersion for our analyses. No geographical con-
siderations will be made in the recruitment process.
Measurements
The following instruments will be used to explore fre-
quency and appropriateness of PDU and its associations,
i.e. patient, ECP, nurse and physical environment related
Figure 1 A conceptual framework on psychotropic drug use in nursing homes and its associations.
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tive and qualitative measures.Quantitative measures
Frequency and appropriateness of PDU, primary outcome
PDU will be classified using the Anatomical Therapeuti-
cal Chemical (ATC) classification [29] and grouped into
antipsychotics, anxiolytics, hypnotics, antidepressants, anti-
convulsants and anti-dementia drugs.
For determining appropriateness of psychotropic drug
use a screening tool will be developed, based on the
Medication Appropriateness Index (MAI). The MAI was
developed in 1992 [30] to determine the drug’s appropri-
ateness for individual patients on 10 items and is proven
to be reliable [31] and applicable in the Dutch nursing
home setting [32]. However, the MAI is not specifically
developed as a tool to screen medical files for appropri-
ateness of prescription of individual psychotropic drugs
in dementia and thus does not sufficiently suit the needs
for this study. We will therefore adapt the original MAI
and develop an instrument that screens medical files for
appropriateness of psychotropic drug prescription in de-
mentia. The instrument will primarily screen PDs based
on the Dutch association of ECP and community geria-
tricians (Verenso) guideline for problem behavior [23].
The instrument will also include information about in-
teractions and contraindications that originates from the
database of the Royal Dutch Association for the ad-
vancement of Pharmacy (KNMP) [33]. PD information
that is not provided by the Dutch Verenso guideline,will be derived from ‘Farmacotherapeutisch Kompas’ [34],
published by the Dutch Health Care Insurance Board
(CVZ) and based on the summary of product characteris-
tics (SPC) [35]. Items will be weighted by an expert panel
of pharmacists and ECPs who categorize the relative con-
tribution of each item to the level of drug appropriateness.Patient factors
NPS will be assessed with the validated Dutch version of
the 12-item Neuropsychiatric Inventory- Questionnaire
(NPI-Q) [36,37]. The NPI-Q assesses NPS in dementia
and caregiver distress. The NPI-Q measures the occur-
rence and severity of NPS on a three-point Likert scale
and associated caregiver burden on a five-point Likert
scale. Additionally, frequency of agitation and aggression
will be assessed with the Cohen-Mansfield Aggression In-
ventory (CMAI) [38], of which the original and the trans-
lated Dutch version has been proven reliable and valid
[39,40]. The CMAI consists of 29 individual items, each
rated at a seven-point Likert scale, combined to 3 subscales
of (physically) aggressive, physically non-aggressive and ver-
bally agitated behavior [39]. Information about other pa-
tient characteristics that will be derived from patients’
charts are: duration of institutionalization, dementia-type,
number of falls, demographic characteristics (date of birth,
sex), the use of activities, the use of psychosocial interven-
tions (reality orientation training, reminiscence, validation,
aromatherapy, music therapy, light therapy, psychoeduca-
tion, sensory activation/snoezelen, multisensory stimula-
tion, cognitive stimulation and psychomotor therapy) and
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use of table stand or chair at table, forced or camouflaged
administration of sedative medication, fixing patients
with tools (tires, span sheets, tear suits, wristbands,
swedish bands), seclude in room with/without the door
locked, forced administration of fluid or food and use of
electronic alerts).
ECP factors
‘Attitude to dementia care’ will be measured by Approaches
to Dementia Questionnaire (ADQ) [41]. The ADQ consists
of 19 items, on a five-point Likert scale and measures hope-
fulness and person-centredness of professionals in demen-
tia care. Higher scores indicate positive attitudes. The total
score ranges from 19–95, the 8-item sub score ‘Hope’ from
8–40, and the 11-item sub score ‘Person-centeredness’ from
11–55. Information about demographic characteristics of
the physician/ECP will be collected: age, sex, years of work
experience, number of years since education/specialization.
Nurse factors
Experienced organizational culture will be measured with
the Competing Values Framework Scale (CVFS) [42], the
validated Dutch version [43], a 6-item scale where four
phrases need to be set in an order of personal relevance.
The CVFS assesses the 6 dimensions of the competing
values framework [44]: dominant organizational charac-
teristic, administration, management style, organizational
glue, strategic emphasis and criteria for success.
Workload will be assessed with a workload question-
naire ‘werkdruklijst’ developed by De Jonge [45,46]. This
scale consist of 10 items about unit workload, each item
can be scored on a five-point Likert scale.
Situations, feelings and thoughts about dementia care
will also be administered, with a 29-item scale, which will
be published as the Strain in dementia Care (SDC) scale
(Michael Bird and Anna-Karin Edberg, personal commu-
nication 2013). There’s a four-point Likert scale for each
item, also a score on another four-point Likert scale can
be given for professional caregiver burden related to the
item. Higher scores indicate high workload.
Job satisfaction will be measured with the Maastricht
Work Satisfaction Scale for Healthcare (MAS-GZ) [47];
a 21-item, five-point Likert scale that focuses on nursing
staff satisfaction. It consist of seven subscales with three
items each about satisfaction with: quality of care, oppor-
tunities of self-actualization/growth, supervisor, possibi-
lities for promotion, clarity of tasks and rules, contact
with colleagues and contact with patients.
‘Attitude to dementia care’ will be measured by the
ADQ (see physician level) [41].
Information about demographic characteristics of the
nurse will be collected: age, sex, educational level, work
experience, number of years since education.Factors of the physical environment
Physical environmental characteristics of the DSCU will
be assessed using the Therapeutic Environment Screening
Survey for Nursing Homes (TESS-NH) [48]. The TESS-
NH contains 84 discrete items plus an open global scale
that covers 13 domains, i.e. number of patients on unit,
exit control, maintenance, cleanliness, safety, orientation/
cueing, privacy, unit autonomy, outdoor access, lighting,
noise, visual/tactile stimulation, space/seating and fami-
liarity/home likeliness [48].
Other information about DSCU characteristics that will
be collected are: number of staff per unit, number of staff
during different shifts.
Qualitative interviews, ECP and nurse level
The ECP and 1–2 members of nursing staff will be inter-
viewed about PDU. The qualitative interviews will be
semi-structured and based on the Straussian grounded
theory approach [49,50]. Interviews will be guided by a
checklist of the following (relevant) topics: influence of
psychosocial environment (relatives and other patients),
PD prescription in practice, own beliefs, beliefs of col-
leagues, beliefs of patient’s family, PDU now and in the
past, influence of the institution, best solutions for NPS,
education, politics and media (see Table 1).
Data analysis
Quantitative (descriptive and multivariate) and qualita-
tive analyses will be performed. For quantitative data
analysis a multilevel model is built to investigate the po-
tential associations with the frequency of PDU and with
the appropriateness of PDU, taken into account that
appropriateness of PDU is nested within DSCUs.
Data collection and analysis of the qualitative semi-
structured interviews will be conducted as an iterative
process with saturation as a guiding principle [51], im-
plying interviews will be carried out until knowledge
saturation is reached. This is known as the constant
comparative method, which is part of the grounded
theory approach [51].
Sample size
According to the n/10 rule [52,53] 360 patients are suffi-
cient to study the number of variables needed for this
study. 67% of the patients are expected to use PDs, which
means that in total 540 patients need to be recruited.
Regarding good sampling and an average cluster size of
15 patients per DSCU, 36 DSCUs of twelve different nursing
homes will be recruited.
Ethical approval
The study is undertaken in accordance with the decla-
ration of Helsinki and will be carried out in accordance
with the applicable rules in the Netherlands. According
Table 1 Mixed methods research parameters/instruments
Quantative Parameters Instruments Registered by
Patient level Frequency of PDU ATC classification codes Researchers
Appropriateness of PDU To be announced Researchers
Neuropsychiatric symptoms NPI-Q Nurse (web based)
Agitation and aggression CMAI Nurse (web based)
Other patient characteristics Case report file Researchers
Physician level Attitude to dementia care ADQ ECP (web based)
Nurse level Demographic characteristics Case report file ECP (web based)
Organizational culture CVFS Nurse (web based)
Physical environmental level. Workload/burnout SDC +Werkdruk (De Jonge) Nurse (web based)
Work satisfaction MAS-GZ Nurse (web based)
Attitude to dementia care ADQ Nurse (web based)
Demographic characteristics Case report file Nurse (web based)
Physical environment TESS-NH Researchers
Other DSCU characteristics Case report file Researchers
Qualitative
Attitudes and beliefs Relevant qualitative factors ECP Semi structured interview Researchers
Relevant qualitative factors nurse Semi structured interview Researchers
Psychotropic drug use (PDU), Anatomical Therapeutical Chemical (ATC), Neuropsychiatric Inventory- Questionnaire (NPI-Q), Cohen-Mansfield Aggression Inventory (CMAI),
Approaches to Dementia Questionnaire (ADQ), Elderly Care Physician (ECP), Competing Values Framework Scale (CVFS), Strain in dementia Care (SDC), the Maastricht
Work Satisfaction Scale for Healthcare ’Maastrichtse Arbeidssatisfactie Schaal voor de Gezondheiszorg’ (MAS-GZ), Therapeutic Environment Screening Survey for Nursing
Homes (TESS-NH).
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Nijmegen, the Netherlands, the study does not need to
be conducted according to the Medical Research Involv-
ing Human Subjects Act (WMO), because patients will
not be directly involved. Relatives, if not available other
representatives, of patients will be informed and asked if
they object to the collection of data. If the relatives or
representatives object, patients will be excluded from the
data collection.
Discussion
The high rates of long-term PDU [9] in combination
with the risk of major and hazardous side effects, limited
evidence for efficacy, long-term inefficacy [15,21,22] and
guidelines recommending to regularly evaluate PDU [23],
make it crucial to study PDU appropriateness and its
associations.
It is hypothesized that the frequency as well as appropri-
ateness of PDU varies between DSCUs, because of factors
related to patient, ECP, nurse and physical environment,
as described in a conceptual framework (Figure 1). More
specifically, it is expected that factors like workload and
staff distress influence the appropriateness of PDU.
A strength of this study is that the recruitment focuses
on nursing homes/ DSCUs with low versus those with high
PDU. Knowledge about extreme, i.e. low or high, PDU and
its associations is most important in dementia care. Al-
though the instrument used for measuring appropriatenessof PDU needs to be developed specifically for this study,
no other instruments known are suitable to investigate the
appropriateness of PDU for NPS. However, it should be
taken into account that the instruments’ assessment of
appropriateness of PDU relies on medical files, which may
be subjected to bad reporting. Yet, in our view this proce-
dure is considered to be more objective than personal
reports of ECPs.
Many of the instruments used for this study are well
known in this field of research, and will contribute to
giving clear insight in factors related to PDU, which can
be used in improving nursing home patient care.
The mixed design of the study is another strength of this
study, interviewing ECPs and nurses can reveal relevant
factors that are not measured with quantitative instru-
ments. So, this study not only gives insight into frequency
and appropriateness of PDU, but also into a diversity of
possible associations, which can be used in future quanti-
tative research.
PROPER I will provide insight in associations of (ap-
propriateness of ) PDU and thus the barriers of optimal
prescription, which is the first step towards safer PDU.
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